Clover Corporation Ltd
ASX:CLV

Watchlist Manager
Clover Corporation Ltd Logo
Clover Corporation Ltd
ASX:CLV
Watchlist
Price: 0.445 AUD Market Closed
Market Cap: 74.3m AUD
Have any thoughts about
Clover Corporation Ltd?
Write Note

Clover Corporation Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Clover Corporation Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Clover Corporation Ltd
ASX:CLV
Cash from Financing Activities
-AU$2.7m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
2%
Hazer Group Ltd
ASX:HZR
Cash from Financing Activities
AU$26.9m
CAGR 3-Years
45%
CAGR 5-Years
62%
CAGR 10-Years
N/A
Titomic Ltd
ASX:TTT
Cash from Financing Activities
AU$8.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
First Graphene Ltd
ASX:FGR
Cash from Financing Activities
AU$2.8m
CAGR 3-Years
-28%
CAGR 5-Years
-12%
CAGR 10-Years
2%
Leaf Resources Ltd
ASX:LER
Cash from Financing Activities
AU$6.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Advance ZincTek Ltd
ASX:ANO
Cash from Financing Activities
AU$1.7m
CAGR 3-Years
-11%
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Clover Corporation Ltd
Glance View

Market Cap
74.3m AUD
Industry
Chemicals

Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company is headquartered in Melbourne, Victoria and currently employs 53 full-time employees. The Company’s geographical segments include Australia/New Zealand, Asia, Europe and America. The firm is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. The company focuses on developing nutrients for use in foods or as nutritional supplements. The firm provides lipid-based ingredients for the food industry. The company focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. The company uses tuna oil, which has docosahexaenoic acid (DHA) for brain, nerve and eye tissue development in babies and infants. The company has a technology license for the encapsulation of marine and algal oils. The firm has a manufacturing plant for tuna oils and related products in Altona, Victoria.

CLV Intrinsic Value
0.917 AUD
Undervaluation 51%
Intrinsic Value
Price

See Also

What is Clover Corporation Ltd's Cash from Financing Activities?
Cash from Financing Activities
-2.7m AUD

Based on the financial report for Jul 31, 2024, Clover Corporation Ltd's Cash from Financing Activities amounts to -2.7m AUD.

What is Clover Corporation Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
2%

Over the last year, the Cash from Financing Activities growth was 45%. The average annual Cash from Financing Activities growth rates for Clover Corporation Ltd have been 26% over the past three years , and 2% over the past ten years .

Back to Top